Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Anti-tumour Activity of ASK120067 in Locally Advanced and Metastatic Non Small Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial updating safety, tolerability, pharmacokinetics, and anti-tumor activity of ASK120067 in locally advanced and metastatic non-small cell…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• ASK120067

Snippet

Sponsor: Jiangsu Aosaikang Pharmaceutical Co., Ltd. | Conditions: Locally Advanced or Metastatic NSCLC | Phase 1, Phase 2 | Status: UNKNOWN